Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
면역 요법은 SARS-CoV-2 감염으로부터 암 환자를 보호할 수 있습니다: 단일 센터 후향적 분석
Research
[키워드] 95% confidence interval
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
analyzed
Campania
Cancer
cancer patient
Cancer patients
Chemotherapy
Cohort
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 infection
effect of treatment
Ensuring
examined
frailty
Gender
global pandemic
group
healthcare providers
Healthcare system
Healthcare systems
ICIs
IgG
IgM
Immune checkpoint inhibitors
Immunotherapy
IRCCS
Logistic
mandatory
matching
Naple
Naples
no statistically significant difference
Odds ratio
oncology
Patient
Performing
positive
Preliminary data
propensity score matching
proportion
PROTECT
protective factor
resulting
Retrospective analysis
SARS-CoV-2
SARS-CoV-2 infections
SARS-CoV-2 seropositivity
score
Seropositivity
severe acute respiratory syndrome Coronavirus
significantly
single-center
statistically significant difference
subject
treated
Treatment
Tumor
tumor stage
unique
[DOI] 10.1186/s12967-021-02798-2 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12967-021-02798-2 PMC 바로가기 [Article Type] Research